Candriam announces an important leadership transition within its Thematic Global Equity platform, and related fund management changes to its healthcare strategies, including strategies investing in the biotechnology sector, life care and in the fight against cancer.

Candriam announces a strategic evolution of its Emerging Market Equity team, effective 1 February 2024.

In our 2022 Engagement report, we offered a case study describing how we begin a topical campaign.

At Candriam, we are both more active and more demanding in our engagement activities, an attitude shared by several other investors, mostly European.

Candriam is pleased to announce the appointment of Nicolas Forest, Candriam’s Global Head of Fixed Income since 2013, as its new Chief Investment Officer (CIO), effective on May 1, 2023.

We are excited to share that our CEO, Naïm Abou-Jaoudé, has been named CEO of New York Life Investment Management (NYLIM).

In the context of the European measures taken against Russia and Belarus, management companies are particularly concerned by the provisions of Article 5f of the amended EU Regulation 833/2014 for Russia and Regulation 398/2022 of 9 March 2022 for Belarus.

First and foremost, our thoughts are with the Ukrainian people at this terrible and uncertain time. Candriam and its employees are deeply saddened by the events we are seeing unfold, and deplore the human tragedy this brings.